<!DOCTYPE html>
<html lang="en">
	<head>
    	<meta charset="utf-8">
    	
    	<meta name="keywords" content="one, two, three">

		<title>Technology/Topic</title>


		<link rel="stylesheet" href="css/normalize.css">
		<link rel="stylesheet" href="css/impact.css">
	</head>


	<header>
			<nav> 
				<ul class="reducemargin">

					<li class="border1"><a href="index.html"><button class="button"> Home page</button></a></li>
					<li class="tech"><a href="TechnologyTopic.html"><button class="button">Technology/ Topic </button></a></li>
					<li class="choi"><a href="impact.html"><button class="button">The Impact on Society </button></a></li>
					<li class="ethical"><a href="Ethicalreflections.html"><button class="button">Ethical reflections </button></a></li>
					<li class="adv"><a href="Advantages.html"><button class="button">Advantages </button></a></li>
					<li class="dis"><a href="Disadvantages.html"><button class="button">Disadvantages </button></a></li>
					<li class="choi"><a href="Choices.html"><button class="button">Choices </button></a></li>
					<li class="ref"><a href="References.html"><button class="button">References</button> </a></li>
					<li class="PS"><a href="Processsupport.html"><button class="button">Process support</button> </a></li>
					<li class="GT"><a href="Somatic.html"><button class="button"> Somatic Gene Therapy</button> </a></li>
					<li class="Mech"><a href="Mechanism.html"><button class="button"> CRISPR Mechanism</button> </a></li>
					
				</ul>
			</nav>

			<section class="secondsection">
				<h2> <center>CRISPR applications in cancer treatment</center> </h2>

			</section>

			<section class="thirdsection">
				<h2><u>The impact of CRISPR on society</u></h2>
			</section>
			<section class="fourthsection">
				<p class="marginadded">Most importantly, Crispr gives those who suffer from diseases that are incurable or do not have many therapeutic alternatives new hope. Crispr has the ability to modify the human genome and tailor medicine so that it is utilized only when necessary for a particular person's body. This would lead to fewer adverse drug reactions, quicker patient recovery, and a faster pace of new drug development. As novel medicines and disease control might be implemented thanks to Crispr, it would be possible to treat or perhaps completely eradicate several human diseases and tumors. Cancers, hereditary muscle mutations including Duchenne muscular dystrophy, leukemia and HIV are the main subjects of several current crispr studies. Only individuals who have tried every other form of treatment should be given the option of this technique, which is still extremely new. The use of cas9 to remove duplicated genes or replace the gene to make it functional again can help some monogenic diseases (Hsu et al., 2014). In order to create HIV therapeutic cells, Crispr itself can be utilized to mutate somatic tissues. ZF nucleases were employed in clinical trials to successfully knock off the CCR5 receptor and prevent HIV infection. HIV RNA became undetectable in one out of every four patients, and HIV DNA levels dropped in all of the patients (Hsu et al., 2014). These findings demonstrate the efficacy of programmable nucleases. With the HIV virus, crispr can be used to modify the t cells so that they can identify and eliminate the virus rather than being eliminated by it. To particularly target particular tumors, chimeric antigen receptor (CAR) T cells can be altered ex vivo and reinfused into a patient (Hsu et al., 2014). Chinese researchers even conducted a study in which they removed the protein pd-1, which inhibits a cell's immune response and can prevent or treat cancer (Sui et al., 2015). Studies on mice have demonstrated the ability of crispr to prevent genetic illness as well as reverse it. Recently, it was demonstrated that hydrodynamic transport of plasmid DNA expressing Cas9 and sgRNA together with a repair template into the liver of an adult mouse model of tyrosinemia could correct the mutant Fah gene and rescue production of the wild-type Fah protein in about 1 out of 250 cells (Sui et al., 2015). If scientists can make the delivery system more precise, all of these scenarios may come to pass in the future. Effective delivery techniques that target specific disease tissues will be necessary for successful clinical translation (Hsu et al., 2014). These small studies represent a tiny fraction of the genetic disorders and malignancies that need to be studied or treated. Crispr will need to be greatly improved in order to attain high levels of therapeutic efficacy and simultaneously address a wide range of genetic problems (Hsu et al., 2014). The delivery mechanism is yet not developed enough to handle a wide range of disorders. Biotechnologists and scientists are unable to forecast what the long-term implications of altering a person's genome could be because the technology is still in its infancy. A single long-term remedy is preferable to numerous short-term ones, although the implications for long-term repercussions are still unknown (Hsu et al., 2014). Before this technology may be used widely by the general public, safety and physiological implications must be studied. Crispr contributes to the modification of our diet in addition to sickness and genetic immunity. Animals' muscular mass could be increased by the application of Crispr, which could also make agricultural animals more resistant to disease, improve their nutritional value, or make hornless calves that are simpler to handle (Sui et al., 2015). Crops can be genetically modified using the Crispr system to become resistant to pathogenic infections or poor environmental conditions (Hsu et al., 2014). This could supply food to areas where it is difficult to cultivate food or where there are famine issues. The development and testing of Cas9 may make personalized medicine more effective at treating extremely rare genetic variations (Hsu et al., 2014). The creation of tailored medications might reduce the likelihood of patients developing drug resistance or at the very least lengthen the period during which they do not. Genetic engineering has been used to improve the productivity, resistance to pests and disease, and climatic adaptability of major agricultural plants (Sui et al., 2015). Through the development of a new and superior kind of ethanol, Crispr could pave the way for various fuel substitutes in the future.</p>
			</section>

	</header>
	<body>
		
		
		
		
	</body>
</html>
